The origin and application of experimental autoimmune encephalomyelitis (original) (raw)

• Gold, R., Linington, C. & Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953–1971 (2006).
  Article PubMed Google Scholar
• Sriram, S. & Steiner, I. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann. Neurol. 58, 939–945 (2005).
  Article CAS PubMed Google Scholar
• Stuart, G. & Krikorian, K. S. The neuro-paralytic accidents of anti-rabies treatment. Ann. Trop. Med. 22, 327–377 (1928).
  Article Google Scholar
• Balaguer, D. D. G. Un caso de rabia paralítica. Gaceta Médica Catalana 11, 45–57 (1888)(in Spanish).
  Google Scholar
• Bassoe, P. & Grinker, R. R. Human rabies and rabies vaccine encephalomyelitis. Arch. Neurol. Psych. 4, 1138–1160 (1930).
  Article Google Scholar
• Koritschoner, R. & Schweinburg, F. Klinisch und experimentelle beobachtungen über Lähmungen nach Wutschutzimpfung. Z. Immunitats Forsh 42, 217–283 (1925)(in German).
  Google Scholar
• Stuart, G. & Krikorian, K. S. A fatal neuro-paralytic accident of antirabies treatment. Lancet 1, 1123–1125 (1930).
  Article Google Scholar
• Rivers, T. M., Sprunt, D. H. & Berry, G. P. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. Exp. Med. 58, 39–53 (1933).
  Article CAS PubMed PubMed Central Google Scholar
• Rivers, T. M. & Schwentker, F. F. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. Exp. Med. 61, 689–702 (1935).
  Article CAS PubMed PubMed Central Google Scholar
• Schwentker, F. F. & Rivers, T. M. The antibody reseponse of rabbits to injection of emulsions and extracts of homologous brain. J. Exp. Med. 60, 559–574 (1934).
  Article CAS PubMed PubMed Central Google Scholar
• Freund, J. & McDermott, K. Sensitisation to horse serum by means of adjuvants. Proc. Soc. Exp. Biol. 49, 548–553 (1942).
  Article CAS Google Scholar
• Kabat, E. A., Wolf, A. & Bezer, A. E. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. J. Exp. Med. 85, 117–130 (1947).
  Article CAS PubMed PubMed Central Google Scholar
• Morgan, I. M. Allergic encephalomyelitis in monkeys in response to injection of normal monkey nervous tissue. J. Exp. Med. 85, 131–140 (1947).
  Article CAS PubMed PubMed Central Google Scholar
• Freund, J., Stern, E. R. & Pisini, T. M. Isoallergic encephalomyelitis and radiculitis in guinea pigs after one injection of brain and mycobacteria in water-in-oil emulsion. J. Immunol. 57, 179–194 (1947).
  CAS PubMed Google Scholar
• Wolf, A., Kabat, E. A. & Bezer, A. E. The pathology of acute disseminated encephalomyelitis produced experimentally in the rhesus monkey and its resemblance to human demyelinating disease. J. Neuropath. Exp. Neurol. 6, 333–357 (1947).
  Article CAS PubMed Google Scholar
• Morrison, L. R. Disseminated encephalomyelitis experimentally produced by the use of homologous antigen. Arch. Neurol. Psychiat. 58, 391–416 (1947).
  Article CAS PubMed Google Scholar
• Lumsden, C. E. Experimental allergic encephalomyelitis II — on the nature of the encephalitogenic agent. Brain 27, 517–537 (1949).
  Article Google Scholar
• Olitsky, P. K. & Yager, R. H. Experimental disseminated encephalomyelitis in white mice. J. Exp. Med. 90, 213–223 (1949).
  Article CAS PubMed PubMed Central Google Scholar
• Lipton, M. M. & Freund, J. Encephalomyelitis in the rat following intracutaneous injection of central nervous system tissue with adjuvant. Proc. Soc. Exp. Biol. NY 81, 260–261 (1952).
  Article CAS Google Scholar
• Tal, C., Laufer, A. & Behar, A. J. An experimental demyelinative disease in the Syrian hamster. Br. J. Exp. Pathol. 39, 158–164 (1958).
  CAS PubMed PubMed Central Google Scholar
• Thomas, L., Paterson, P. Y. & Smithwick, B. Acute disseminated encephalomyelitis following immunization with homologous brain extracts: I. Studies on the role of a circulating antibody in the production of the condition in dogs. J. Exp. Med. 92, 133–152 (1950).
  Article CAS PubMed PubMed Central Google Scholar
• Innes, J. R. M. Experimental allergic encephalitis: attempts to produce the disease in sheep and goats. J. Comp. Path. 61, 241–250 (1951).
  Article CAS PubMed Google Scholar
• Genain, C. P. et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96, 2966–2974 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Ranzenhofer, E. R., Lipton, M. M. & Steigman, A. J. Effect of homologous spinal cord in Freund's adjuvant on cockerel comb, testicular and body growth. Proc. Soc. Exp. Biol. NY 99, 280–282 (1958).
  Article CAS Google Scholar
• Adams, R. D. & Kubik, C. S. The morbid anatomy of the demyelinative diseases. Am. J. Med. 12, 510–546 (1952).
  Article CAS PubMed Google Scholar
• Ferraro, A. Pathology of demyelinating diseases as an allergic reaction of the brain. Arch. Neurol. Psych. 4, 443–483 (1944).
  Article Google Scholar
• Steinman, L. & Zamvil, S. S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60, 12–21 (2006).
  Article CAS PubMed Google Scholar
• Teitelbaum, D., Meshorer, A., Hirshfeld, T., Arnon, R. & Sela, M. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur. J. Immunol. 1, 242–248 (1971).
  Article CAS PubMed Google Scholar
• Lublin, F. D., Lavasa, M., Viti, C. & Knobler, R. L. Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone. Clin. Immunol. Immunopathol. 45, 122–128 (1987).
  Article CAS PubMed Google Scholar
• Yednock, T. A. et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 356, 63–66 (1992).
  Article CAS PubMed Google Scholar
• Langer-Gould, A., Atlas, S. W., Green, A. J., Bollen, A. W. & Pelletier, D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 353, 375–381 (2005).
  Article CAS PubMed Google Scholar
• Bielekova, B. et al. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nature Med. 6, 1167–1175 (2000).
  Article CAS PubMed Google Scholar
• van Oosten, B. W. et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47, 1531–1534 (1996).
  Article CAS PubMed Google Scholar
• Waksman, B. H., Porter, H., Lees, M. D., Adams, R. D. & Folch, J. A study of the chemical nature of components of bovine white matter effective in producing allergic encephalomyelitis in the rabbit. J. Exp. Med. 100, 451–471 (1954).
  Article CAS PubMed PubMed Central Google Scholar
• Ferraro, A. & Roizin, L. Production of experimental encephalomyelitis with calcium acetate compound extracted from brain tissue. J. Neuropath. Exp. Neurol. 10, 394–407 (1951).
  Article CAS Google Scholar
• Laatsch, R. H., Kies, M. W., Gordon, S. & Alvord, E. C. Jr. The encephalomyelitic activity of myelin isolated by ultracentrifugation. J. Exp. Med. 115, 777–788 (1962).
  Article CAS PubMed PubMed Central Google Scholar
• Einstein, E. R., Robertson, D. M., DiCaprio, J. M. & Moore, W. The isolation from bovine spinal cord of a homogeneous protein with encephalitogenic activity. J. Neurochem. 9, 353–361 (1962).
  Article CAS PubMed Google Scholar
• Kibler, R. F. et al. Immune response of Lewis rats to peptide C1 (residues 68–88) of guinea pig and rat myelin basic proteins. J. Exp. Med. 146, 1323–1331 (1977).
  Article CAS PubMed Google Scholar
• Fritz, R. B., Chou, C. H. & McFarlin, D. E. Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J × PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. J. Immunol. 130, 191–194 (1983).
  CAS PubMed Google Scholar
• Fritz, R. B., Skeen, M. J., Chou, C. H., Garcia, M. & Egorov, I. K. Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J. Immunol. 134, 2328–2332 (1985).
  CAS PubMed Google Scholar
• Zamvil, S. S. et al. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324, 258–260 (1986).
  Article CAS PubMed Google Scholar
• Zamvil, S. S. et al. Predominant expression of a T cell receptor Vβ gene subfamily in autoimmune encephalomyelitis. J. Exp. Med. 167, 1586–1596 (1988).
  Article CAS PubMed Google Scholar
• Acha-Orbea, H. et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54, 263–273 (1988).
  Article CAS PubMed Google Scholar
• Burns, F. R. et al. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V α and V β chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J. Exp. Med. 169, 27–39 (1989).
  Article CAS PubMed Google Scholar
• Heber-Katz, E. & Acha-Orbea, H. The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. Immunol. Today 10, 164–169 (1989).
  Article CAS PubMed Google Scholar
• Sakai, K. et al. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Proc. Natl Acad. Sci. USA 85, 8608–8612 (1988).
  Article CAS PubMed PubMed Central Google Scholar
• Behlke, M. A., Chou, H. S., Huppi, K. & Loh, D. Y. Murine T-cell receptor mutants with deletions of βchain variable region genes. Proc. Natl Acad. Sci. USA 83, 767–771 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Wraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L. & McDevitt, H. O. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59, 247–255 (1989).
  Article CAS PubMed Google Scholar
• Sakai, K. et al. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. Proc. Natl Acad. Sci. USA 86, 9470–9474 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Kappos, L. et al. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. Nature Med. 6, 1176–1182 (2000).
  Article CAS PubMed Google Scholar
• Crowe, P. D., Qin, Y., Conlon, P. J. & Antel, J. P. NBI-5788, an altered MBP83–99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients. Ann. Neurol. 48, 758–765 (2000).
  Article CAS PubMed Google Scholar
• Lyons, G. A. Letter to shareholders, Neurocrine Biosciences Annual Report [online], (2003).
• Sharma, S. D. et al. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. Proc. Natl Acad. Sci. USA 88, 11465–11469 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Spack, E. G. Antigen-specific therapies for the treatment of multiple sclerosis: a clinical trial update. Expert Opin. Investig. Drugs 6, 1715–1727 (1997).
  Article CAS PubMed Google Scholar
• Goodkin, D. E. et al. A phase I trial of solubilized DR2:MBP84–102 (AG284) in multiple sclerosis. Neurology 54, 1414–1420 (2000).
  Article CAS PubMed Google Scholar
• Warren, K. G., Catz, I., Ferenczi, L. Z. & Krantz, M. J. Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment. Eur. J. Neurol. 13, 887–895 (2006).
  Article CAS PubMed Google Scholar
• Bornstein, M. B. et al. A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N. Engl. J. Med. 317, 408–414 (1987).
  Article CAS PubMed Google Scholar
• Johnson, K. P. et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group. Neurology 45, 1268–1276 (1995).
  Article CAS PubMed Google Scholar
• Sela, M., Mozes, E. Therapeutic vaccines in autoimmunity. Proc. Natl Acad. Sci. USA 101 (Suppl. 2), 14586–14592 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Racke, M. K., Martin, R., McFarland, H. & Fritz, R. B. Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation. J. Neuroimmunol. 37, 75–84 (1992).
  Article CAS PubMed Google Scholar
• Kies, M. W. Panel discussion on species variability and multiple antigens in EAE: summary statement. Ann. NY Acad. Sci. 122, 242–244 (1965).
  Article CAS PubMed Google Scholar
• Steinman, L. The coming of age for antigen-specific therapy of multiple sclerosis. Eur. J. Neurol. 13, 793–794 (2006).
  Article CAS PubMed Google Scholar
• Kuerten S. et al. MBP–PLP fusion protein-induced EAE in C57BL/6 mice. J. Neuroimmunol. 177, 99–111 (2006).
  Article CAS PubMed Google Scholar
• Check, E. Nerve inflammation halts trial for Alzheimer's drug. Nature 415, 462 (2002).
  Article CAS PubMed Google Scholar
• Rogers, J., Strohmeyer, R., Kovelowski, C. J. & Li, R. Microglia and inflammatory mechanisms in the clearance of amyloid β peptide. Glia 40, 260–269 (2002).
  Article PubMed Google Scholar
• Esch, T. R., Miskimins, R. & Heber-Katz, E. CAT induces encephalomyelitis in MBP-CAT transgenic mice expressing CAT in oligodendrocytes. Transgene 1, 11–18 (1993).
  Google Scholar
• Hemachudha, T. et al. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N. Engl. J. Med. 316, 369–374 (1987).
  Article CAS PubMed Google Scholar
• Webster, L. T., & Clow, A. D. Propagation of rabies virus in tissue culture. J. Exp. Med. 66, 125–131 (1937).
  Article CAS PubMed PubMed Central Google Scholar
• Cao, Y. et al. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes. Eur. J. Immunol. 36, 207–215 (2006).
  Article CAS PubMed Google Scholar
• Smallwood, L. & Baxter, A. G. On lawnmowers and lay-down miseres. Immunology 111, 252–253 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Levine, S. & Sowinski, R. Experimental allergic encephalomyelitis in inbred and outbred mice. J. Immunol. 110, 139–143 (1973).
  CAS PubMed Google Scholar
• Eylar, E. H., Caccam, J., Jackson, J. J., Westall, F. C. & Robinson, A. B. Experimental allergic encephalomyelitis: synthesis of disease-inducing site of the basic protein. Science 168, 1220–1223 (1970).
  Article CAS PubMed Google Scholar
• Shapira, R., Chou, F. C., McKneally, S., Urban, E. & Kibler, R. F. Biological activity and synthesis of an encephalitogenic determinant. Science 173, 736–738 (1971).
  Article CAS PubMed Google Scholar
• Chou, C. H., Chou, F. C., Kowalski, T. J., Shapira, R. & Kibler, R. F. The major site of guinea-pig myelin basic protein encephalitogenic in Lewis rats. J. Neurochem. 28, 115–119 (1977).
  Article CAS PubMed Google Scholar
• Pettinelli, C. B., Fritz, R. B., Chou, C. H. & McFarlin, D. E. Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J. Immunol. 129, 1209–1211 (1982).
  CAS PubMed Google Scholar
• Sakai, K. et al. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J. Neuroimmunol. 19, 21–32 (1988).
  Article CAS PubMed Google Scholar
• Fritz, R. B., Chou, C. H. & McFarlin, D. E. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J. Immunol. 130, 1024–1026 (1983).
  CAS PubMed Google Scholar
• Lennon, V. A., Wilks, A. V. & Carnegie, P. R. Immunologic properties of the main encephalitogenic peptide from the basic protein of human myelin. J. Immunol. 105, 1223–1230 (1970).
  CAS PubMed Google Scholar
• Carnegie, P. R. Amino acid sequence of the encephalitogenic basic protein from human myelin. Biochem. J. 123, 57–67 (1971).
  Article CAS PubMed PubMed Central Google Scholar
• Fujinami, R. S. & Oldstone, M. B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230, 1043–1045 (1985).
  Article CAS PubMed Google Scholar
• Goldstein, N. P., Kolb, L. C., Mason, H. L., Sayre, G. P. & Karlson, A. G. Relationship of homologous brain proteolipid to allergic encephalomyelitis in guinea pigs. Neurology 3, 609–614 (1953).
  Article CAS PubMed Google Scholar
• Furlan, R. et al. Vaccination with amyloid-β peptide induces autoimmune encephalomyelitis in C57/BL6 mice. Brain 126, 285–291 (2003).
  Article PubMed Google Scholar
• Pellkofer, H. et al. Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. Brain 127, 1822–1830 (2004).
  Article PubMed Google Scholar
• Kojima, K. et al. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J. Exp. Med. 180, 817–829 (1994).
  Article CAS PubMed Google Scholar
• Linington, C. et al. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23, 1364–1372 (1993).
  Article CAS PubMed Google Scholar
• Amor, S. et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153, 4349–4356 (1994).
  CAS PubMed Google Scholar
• Kaye, J. F. et al. The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS). J. Neuroimmunol. 102, 189–198 (2000).
  Article CAS PubMed Google Scholar
• Zamvil, S. et al. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317, 355–358 (1985).
  Article CAS PubMed Google Scholar
• Kabat, E. A., Wolf, A., Bezer, A. E. Rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of brain tissue with adjuvants. Science 104, 362–363 (1946).
  Article PubMed Google Scholar
• Lipton, M. M. & Freund, J. The transfer of experimental allergic encephalomyelitis in the rat by means of parabiosis. J. Immunol. 71, 380–384 (1953).
  CAS PubMed Google Scholar
• Paterson, P. Y. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. Exp. Med. 111, 119–136 (1960).
  Article CAS PubMed PubMed Central Google Scholar
• Waksman, B. H., Arbouys, S. & Arnason, B. G. The use of specific “lymphocyte” antisera to inhibit hypersensitive reactions of the “delayed” type. J. Exp. Med. 114, 997–1022 (1961).
  Article CAS PubMed PubMed Central Google Scholar
• Ben-Nun, A., Wekerle, H. & Cohen, I. R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11, 195–199 (1981).
  Article CAS PubMed Google Scholar
• Schluesener, H. J., Sobel, R. A., Linington, C. & Weiner, H. L. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139, 4016–4021 (1987).
  CAS PubMed Google Scholar
• Fierz, W. et al. Synergism in the pathogenesis of EAE induced by an MBP-specific T-cell line and monoclonal antibodies to galactocerebroside or a myelin oligodendroglial glycoprotein. Ann. NY Acad. Sci. 540, 360–363 (1988).
  Article CAS PubMed Google Scholar
• Jiang, H., Zhang, S. I. & Pernis, B. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256, 1213–1215 (1992).
  Article CAS PubMed Google Scholar
• Koh, D. R. et al. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8−/− mice. Science 256, 1210–1213 (1992).
  Article CAS PubMed Google Scholar
• Genain, C. P. et al. In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J. Clin. Invest. 94, 1339–1345 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Elliott, J. I., Douek, D. C. & Altmann, D. M. Mice lacking αβ+ T cells are resistant to the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 70, 139–144 (1996).
  Article CAS PubMed Google Scholar
• Nataf, S., Carroll, S. L., Wetsel, R. A., Szalai, A. J. & Barnum, S. R. Attenuation of experimental autoimmune demyelination in complement-deficient mice. J. Immunol. 165, 5867–5873 (2000).
  Article CAS PubMed Google Scholar